TD Waterhouse Canada’s Quest Diagnostics DGX Stock Holding History

TD Waterhouse Canada’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.2M	Buy	37,951 +599	+2%	+$118K	0.02%	314
2026 Q1	$7.37M	Sell	37,352 -3,843	-9%	-$747K	0.02%	322
2025 Q4	$7.14M	Buy	41,195 +2,855	+7%	+$520K	0.04%	231
2025 Q3	$6.98M	Buy	38,340 +3,156	+9%	+$560K	0.05%	228
2025 Q2	$6.31M	Buy	35,184 +6,658	+23%	+$1.16M	0.05%	240
2025 Q1	$4.84M	Buy	+28,526	New	+$4.69M	0.04%	264
2023 Q4	–	Sell	-321	Closed	-$52.3K	–	1733
2023 Q3	$52.3K	Buy	321 +304	+1,788%	+$40.5K	﹤0.01%	904
2023 Q2	$2.36K	Sell	17 -17	-50%	-$2.34K	﹤0.01%	1519
2023 Q1	$6.53K	Hold	34	–	–	﹤0.01%	1310
2022 Q4	$7.24K	Hold	34	–	–	﹤0.01%	1274
2022 Q3	$5.81K	Hold	34	–	–	﹤0.01%	1330
2022 Q2	$6K	Hold	34	–	–	﹤0.01%	1351
2022 Q1	$5.81K	Sell	34 -6	-15%	-$836	﹤0.01%	1429
2021 Q4	$7.91K	Buy	+40	New	+$6.09K	﹤0.01%	1380

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

TD Waterhouse Canada's DGX Position: Q2 2026 in Review

TD Waterhouse Canada increased its Quest Diagnostics (DGX) stake by 1.6% in Q2 2026, buying an estimated $118K and bringing the position to 37,951 shares worth $8.2M. The position accounts for 0.02% of the portfolio, ranked #314.

TD Waterhouse Canada first reported a position in DGX in Q4 2021 and has held it in 14 quarters since. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

TD Waterhouse Canada held 37,951 shares of Quest Diagnostics worth $8.2M as of Q2 2026.
TD Waterhouse Canada bought 599 Quest Diagnostics shares in Q2 2026, an estimated $118K.
Quest Diagnostics made up 0.02% of TD Waterhouse Canada's portfolio in Q2 2026, its #314 holding.
TD Waterhouse Canada first reported a position in Quest Diagnostics in Q4 2021 and has held it in 14 quarters since.
629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.